EMA Authorised: Pregabalin Viatris Pharma (previously Pregabalin Pfizer) (pregabalin) — Viatris Healthcare Limited

View source ↗

Summary

The EMA authorised a pregabalin product under the Viatris Pharma marketing authorisation (formerly Pfizer), for anxiety disorders and epilepsy. The active subst…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Epilepsy

Drugs mentioned

• Pregabalin Viatris Pharma (pregabalin)

Snippet

Status: Authorised. Therapeutic area: Anxiety Disorders;Epilepsy. MAH: Viatris Healthcare Limited. Decision date: 05/11/2025